Annual report [Section 13 and 15(d), not S-K Item 405]
Cover
Cover Page
Audit Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Income Statements
Consolidated Statements of Changes in Stockholders' Equity
Consolidated Statements of Cash Flows
Notes to Financial Statements
Nature of Operations and Summary of Significant Accounting Policies
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Year Ended December 31, 2024
Revenue Disclosures
Acquisitions and Divestitures
Property and Equipment
Fair Value Consideration
Debt
Stock-Based Compensation
Income Taxes
Commitments and Contingencies
Segment Reporting
Employee Retention Credit
Related ???Party??? Transaction
Quarterly Financial Data (Unaudited)
Subsequent Events
Insider Trading Arrangements
Insider Trading Policies and Procedures
Cybersecurity Risk Management and Strategy Disclosure
Accounting Policies
Nature of Operations and Summary of Significant Accounting Policies (Policies)
Notes Tables
Nature of Operations and Summary of Significant Accounting Policies (Tables)
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Year Ended December 31, 2024 (Tables)
Revenue Disclosures (Tables)
Acquisitions and Divestitures (Tables)
Property and Equipment (Tables)
Stock-Based Compensation (Tables)
Income Taxes (Tables)
Commitments and Contingencies (Tables)
Segment Reporting (Tables)
Quarterly Financial Data (Unaudited) (Tables)
Subsequent Events (Tables)
Notes Details
Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-Owned or Managed (Details)
Nature of Operations and Summary of Significant Accounting Policies - Narrative (Details)
Nature of Operations and Summary of Significant Accounting Policies - VIE Income Statement (Details)
Nature of Operations and Summary of Significant Accounting Policies - VIE Assets and Liabilities (Details)
Nature of Operations and Summary of Significant Accounting Policies - Reconciliation of of Accounts Receivable Allowance for Credit Losses (Details)
Nature of Operations and Summary of Significant Accounting Policies - Net Loss (Gain) on Disposition or Impairment Related to Continuing Operations (Details)
Nature of Operations and Summary of Significant Accounting Policies - Impairment Losses and Disposal Gains and Losses Recorded in (Loss) Income from Discontinued Operations (Details)
Nature of Operations and Summary of Significant Accounting Policies - (Loss) Earnings Per Common Share (Details)
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Year Ended December 31, 2024 - Consolidated Balance Sheet (Details)
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Year Ended December 31, 2024 - Consolidated Income Statement (Details)
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Year Ended December 31, 2024 - Consolidated Statements of Stockholders' Equity (Details)
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Year Ended December 31, 2024 - Consolidated Statements of Cash Flows (Details)
Revenue Disclosures - Narrative (Details)
Revenue Disclosures - Disaggregation of Revenue (Details)
Revenue Disclosures - Rollforward of Accounts Receivable (Details)
Revenue Disclosures - Rollforward of Contract Liabilities (Details)
Revenue Disclosures - Rollforward of Deferred Franchise and Development Costs (Details)
Revenue Disclosures - Estimated Revenue Related to Performance Obligations (Details)
Acquisitions and Divestitures - Acquisitions, Narrative (Details)
Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details)
Acquisitions and Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)
Acquisitions and Divestitures - Assets and Liabilities of Discontinued Operations (Details)
Acquisitions and Divestitures - Key Components of Cash Flows from Discontinued Operations (Details)
Acquisitions and Divestitures - Corporate Clinic Segment Divestiture, Narrative (Details)
Acquisitions and Divestitures - Held For Sale Assets and Liabilities To Be Disposed Of (Details)
Property and Equipment - Summary of Property and Equipment (Details)
Property and Equipment - Narrative (Details)
Fair Value Consideration (Details)
Debt (Details)
Stock-Based Compensation - Narrative (Details)
Stock-Based Compensation - Valuation Assumptions used for Stock Options (Details)
Stock-Based Compensation - Stock Options Activity (Details)
Stock-Based Compensation - Restricted Stock Activity (Details)
Income Taxes - Income Tax Expense (Details)
Income Taxes - Deferred Tax Assets and Liabilities (Details)
Income Taxes - Narrative (Details)
Income Taxes - Effective Income Tax Reconciliation (Details)
Income Taxes - Uncertain Tax Position Rollforward (Details)
Commitments and Contingencies - Lease Expense and Supplemental Lease Information (Details)
Commitments and Contingencies - Maturities of Lease Liabilities (Details)
Commitments and Contingencies - Narrative (Details)
Segment Reporting - Narrative (Details)
Segment Reporting - Total Revenue and Significant Expense Categories (Details)
Employee Retention Credit (Details)
Related ???Party??? Transaction (Details)
Quarterly Financial Data (Unaudited) (Details)
Subsequent Events - Maturities of Operating Lease Liabilities (Details)
Subsequent Events - Narrative (Details)
Fair Value Consideration (Details)
403 Forbidden
Forbidden
You don't have permission to access this resource.